Kimberly-Clark closes $48.7bn Kenvue deal, moves into beauty

Kimberly-Clark has completed its US$48.7bn acquisition of Kenvue, placing hair and skin brands OGX, Neutrogena and Aveeno under the same ownership as Kleenex, Huggies, Andrex and Kotex.

The deal marks Kimberly-Clark's first major push into the beauty category. For salon and retail professionals who stock OGX shampoos or Neutrogena hair and scalp lines, the change is ownership, not formulation: the brands keep their names, and their new parent says it can now "provide preferred solutions through every stage of life".

The acquisition also brings Kenvue's health brands — Listerine, Tylenol, Benadryl and Nicorette — into the fold. Kenvue itself was spun off from Johnson & Johnson in 2023.

What did the CEO say?

"Today marks a defining moment in Kimberly-Clark's 154-year history as we welcome Kenvue and hit the ground running as one company," said Mike Hsu, Chairman and CEO of Kimberly-Clark. "I am deeply grateful to our Kimberly-Clark and Kenvue teams around the world for enabling this next step."

Hsu framed the merger around category heritage. "We share a rich heritage: pioneering entire categories and forming deep, lifelong bonds with consumers around the world as we help generations of people take care of themselves and their loved ones, every day," he said.

He pointed to demand as the driver. "Now, at a moment when the need for better care is undeniable and growing, we have an urgent opportunity to be there for more people, in more places and across evolving unmet needs."

His closing message set the execution agenda: "Our focus now is to move with speed and purpose to unlock the full potential of this combination. I am confident that our shared commitment to care and strong execution will enable us to deliver generational value for consumers, customers and shareholders."

How will the combined company be structured?

Kimberly-Clark will run four business segments:

• North America
• Asia-Pacific focused markets, including Greater China, Australia/New Zealand, South Korea and Indonesia
• Europe, the Middle East and Africa (EMEA)
• Enterprise markets, covering Latin America including Brazil, India, Southeast Asia and Japan

The company claims it is now positioned to capture growing demand for "science-backed, high-quality and high-performance solutions across everyday needs", according to its statement. That claim belongs to the manufacturer; the market will judge it.

Why did Kenvue sell?

The deal follows a rough patch for the target. Kenvue launched a strategic review of its business in July, against falling sales and job cuts. The spin-off from J&J in 2023 had not stopped the decline, and the review opened the door to consolidation.

For the beauty channel, the practical question is what changes at shelf and in distribution once OGX and Aveeno sit beside Huggies in the portfolio. Kimberly-Clark has signalled speed; the next signals will come from its segment reporting and any brand-level restructuring under the new four-segment structure.